Catalent Inc (CTLT) Gross Profit Margin starting from the first quarter 2024 to first quarter 2023, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Catalent Inc   (NYSE: CTLT)


Catalent Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CTLT Gross Profit Margin (Sep 30 2024)
Q1 		(Jun 30 2024)
Q4 		(Mar 31 2024)
Q3 		(Dec 31 2023)
Q2 		(Sep 30 2023)
Q1
Y / Y Revenue Change 4.18 %
Seq. Revenue Change -21.37 %
Revenue In Millions $1,023.00
Gross Profit Margin 17.69 %
Gross Profit Margin Total Ranking # 3241
Gross Profit In Millions $181.00
Y / Y Gross Profit Change 7.1 %
Seq. Gross Profit Change -52.86 %


Commenting First Quarter 2024 Gross Profit Margin
Catalent Inc experienced contraction in Gross Profit by -52.86 % to $1,023 millions and Revenue by -21.37 %, while Gross Profit Margin fell to 17.69 %, below company*s average Gross Profit Margin.


Observing first quarter 2024 results within Major Pharmaceutical Preparations industry 148 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 2776 to 3241.
Learn about Gross Margin
CTLT's Gross Profit Margin first quarter 2024 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 149
Healthcare Sector # 459
Overall # 3195

Gross Profit Margin Statistics
High Average Low
36.97 % 29.47 % 10.81 %
(Jun 30 2021)   (Jun 30 2020)


CTLT Gross Income Trends • More of CTLT's Profitabilty Ratios • CTLT Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
CTLT's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
CTLT's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for CTLT's Competitors
Gross Profit Margin Profit Margin for Catalent Inc 's Suppliers
Gross Profit Margin Profit Margin for CTLT's Customers

You may also want to know
CTLT's Annual Growth Rates CTLT's Profitability Ratios CTLT's Asset Turnover Ratio CTLT's Dividend Growth
CTLT's Roe CTLT's Valuation Ratios CTLT's Financial Strength Ratios CTLT's Gross Profit Growth
CTLT's Roa CTLT's Inventory Turnover Ratio CTLT's Growth Rates CTLT's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2024, within Major Pharmaceutical Preparations Industry Gross Profit MarginSep 30 2024 MRQ Gross ProfitSep 30 2024 MRQ Revenue
Igc Pharma Inc   48.06 %$ 0.198  Millions$ 0.412  Millions
Cv Sciences Inc   47.06 %$ 1.778  Millions$ 3.778  Millions
Elite Pharmaceuticals Inc   45.05 %$ 8.197  Millions$ 18.197  Millions
Tonix Pharmaceuticals Holding Corp   44.90 %$ 1.267  Millions$ 2.822  Millions
Keenova Therapeutics Plc  43.77 %$ 221.100  Millions$ 505.100  Millions
Maravai Lifesciences Holdings Inc   43.52 %$ 28.374  Millions$ 65.200  Millions
Lftd Partners Inc   43.24 %$ 3.758  Millions$ 8.692  Millions
Bespoke Extracts Inc  41.44 %$ 0.115  Millions$ 0.277  Millions
Veru Inc   40.37 %$ 2.687  Millions$ 6.657  Millions
Inmed Pharmaceuticals Inc  39.02 %$ 0.493  Millions$ 1.265  Millions
Viatris Inc   38.90 %$ 1,459.200  Millions$ 3,751.200  Millions
Amarin Corp Plcuk  38.48 %$ 16.276  Millions$ 42.298  Millions
Amneal Pharmaceuticals Inc   38.42 %$ 269.558  Millions$ 701.558  Millions
Zevra Therapeutics Inc   37.67 %$ 1.392  Millions$ 3.695  Millions
Opko Health Inc   37.31 %$ 64.785  Millions$ 173.632  Millions
Perrigo Company Plc  37.19 %$ 404.400  Millions$ 1,087.400  Millions
60 Degrees Pharmaceuticals Inc   36.67 %$ 0.223  Millions$ 0.608  Millions
Sunshine Biopharma Inc   33.98 %$ 2.866  Millions$ 8.435  Millions
Phibro Animal Health Corporation  32.18 %$ 83.495  Millions$ 259.495  Millions
Organigram Global Inc   29.73 %$ 36.403  Millions$ 122.438  Millions
Blue Water Vaccines Inc  25.91 %$ 0.105  Millions$ 0.407  Millions
Rockwell Medical inc   22.09 %$ 6.239  Millions$ 28.239  Millions
Lifecore Biomedical Inc   22.09 %$ 5.387  Millions$ 24.387  Millions
Hcw Biologics Inc   20.00 %$ 0.085  Millions$ 0.426  Millions
Catalent Inc   17.69 %$ 181.000  Millions$ 1,023.000  Millions
Bgm Group Ltd  17.06 %$ 4.115  Millions$ 24.115  Millions
Integrated Biopharma Inc  10.25 %$ 1.371  Millions$ 13.371  Millions
Scorpius Holdings inc   7.63 %$ 0.070  Millions$ 0.922  Millions
Scienture Holdings Inc   5.99 %$ 0.004  Millions$ 0.065  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.